DECREASED LOCOMOTOR-ACTIVITY PRODUCED BY REPEATED, BUT NOT SINGLE, ADMINISTRATION OF MURINE-RECOMBINANT INTERFERON-GAMMA IN MICE

被引：18
|
作者：
WEINBERGER, SB [1 ]
SCHULTEIS, G [1 ]
FERNANDO, AG [1 ]
BAKHIT, C [1 ]
MARTINEZ, JL [1 ]
机构：
[1] GENENTECH INC,DEPT PHARMACOL SCI,SAN FRANCISCO,CA 94080
来源：
LIFE SCIENCES | 1988年 / 42卷 / 10期
关键词：
D O I：
10.1016/0024-3205(88)90564-4
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1085 / 1090
页数：6
相关论文
共 40 条
  • [31] A single administration of recombinant human interleukin-12 is associated with increased expression levels of interferon-gamma and signal transducer and activator of transcription in healthy subjects
    Trudeau, C
    Cotreau, MM
    Stonis, L
    Dykstra, KH
    Oestreicher, JL
    Strahs, A
    Dorner, AJ
    Van Cleave, VH
    Trepicchio, WL
    Schwertschlag, US
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (06): : 649 - 658
  • [32] INDUCTION OF AN ENDOGENOUS TUMOR NECROSIS FACTOR IN MICE BY MURINE RECOMBINANT INTERFERON-GAMMA COMBINED WITH A LIPID-A SUBUNIT ANALOG (GLA-60) OF LOW TOXICITY
    SAIKI, I
    MAEDA, H
    SAKURAI, T
    MURATA, J
    IIDA, J
    KISO, M
    HASEGAWA, A
    AZUMA, I
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 29 (02) : 101 - 108
  • [33] SYNERGISTIC EFFECT OF HUMAN LACTOFERRIN AND RECOMBINANT MURINE INTERFERON-GAMMA ON DISEASE PROGRESSION IN MICE INFECTED WITH THE POLYCYTHEMIA-INDUCING STRAIN OF THE FRIEND-VIRUS COMPLEX
    LU, L
    SHEN, RN
    ZHOU, SZ
    SRIVASTAVA, C
    HARRINGTON, M
    MIYAZAWA, K
    WU, B
    LIN, ZH
    RUSCETTI, S
    BROXMEYER, HE
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1991, 54 (02) : 117 - 124
  • [34] SYNERGISTIC ANTITUMOR EFFECT OF RECOMBINANT MURINE INTERFERON-GAMMA (R-MUIFN-GAMMA) AND RECOMBINANT HUMAN INTERLEUKIN-2 (R-IL2) AGAINST EL4 THYMOMA-BEARING MICE
    SATO, K
    MAEKAWA, R
    HOJO, K
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 825 - 825
  • [35] REQUIREMENT FOR NATURAL-KILLER CELL-PRODUCED INTERFERON-GAMMA IN DEFENSE AGAINST MURINE CYTOMEGALOVIRUS-INFECTION AND ENHANCEMENT OF THIS DEFENSE PATHWAY BY INTERLEUKIN-12 ADMINISTRATION
    ORANGE, JS
    WANG, BP
    TERHORST, C
    BIRON, CA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04): : 1045 - 1056
  • [36] RECOMBINANT MURINE INTERFERON-GAMMA INHIBITS THE FUSION OF MOUSE ALVEOLAR MACROPHAGES INVITRO BUT STIMULATES THE FORMATION OF OSTEOCLAST-LIKE CELLS ON IMPLANTED SYNGENEIC BONE PARTICLES IN MICE INVIVO
    VIGNERY, A
    NIVENFAIRCHILD, T
    SHEPARD, MH
    JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (06) : 637 - 644
  • [37] SUPPRESSIVE BIOLOGICAL-ACTIVITY OF A SYNTHETIC PENTAPEPTIDE ON HIGHLY ENRICHED HUMAN AND MURINE MARROW HEMATOPOIETIC PROGENITORS - SYNERGISM WITH RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA
    LU, L
    FOA, P
    CHILLEMI, F
    SHEN, RN
    LIN, ZH
    CAROW, C
    BROXMEYER, HE
    EXPERIMENTAL HEMATOLOGY, 1989, 17 (09) : 935 - 941
  • [38] SINGLE AND REPEATED ADMINISTRATION OF NEUROLEPTIC DRUGS TO RATS - EFFECTS ON STRIATAL DOPAMINE-SENSITIVE ADENYLATE-CYCLASE AND LOCOMOTOR ACTIVITY PRODUCED BY TRANYLCYPROMINE AND L-TRYPTOPHAN OR L-DOPA
    HEAL, DJ
    GREEN, AR
    BOULLIN, DJ
    GRAHAMESMITH, DG
    PSYCHOPHARMACOLOGY, 1976, 49 (03) : 287 - 300
  • [39] ELEVATION OF 2',5'-OLIGOADENYLATE SYNTHETASE-ACTIVITY AND HLA-I ASSOCIATED BETA-2-MICROGLOBULIN IN RESPONSE TO RECOMBINANT INTERFERON-GAMMA ADMINISTRATION IN CHRONIC HBEAG-POSITIVE HEPATITIS
    QUIROGA, JA
    MORA, I
    PORRES, JC
    CARRENO, V
    JOURNAL OF INTERFERON RESEARCH, 1988, 8 (06): : 755 - 763
  • [40] ADOPTIVE CHEMO-IMMUNOTHERAPY (ACTT) OF MURINE LEUKEMIA - ENHANCED ACTIVITY OF A CYTO-TOXIC LYMPHOCYTE-T (CTL) CLONE IN COMBINATION WITH EITHER A HELPER LYMPHOCYTE-T CLONE (HTL) OR RECOMBINANT INTERFERON-GAMMA (RIFN-GAMMA)
    BOOKMAN, MA
    HORAK, E
    DEGRAAF, PW
    FASEB JOURNAL, 1988, 2 (04): : A661 - A661
1234